[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-research-council-of-norway-iics4all-multi-national-investigator-initiated-cli-2027-01":3,"similar-research-council-of-norway-iics4all-multi-national-investigator-initiated-cli-2027-01":37},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":10,"deadline":11,"deadline_note":12,"duration":9,"trl":13,"relevance":9,"why_relevant":9,"early_career":14,"consortium":15,"first_seen":16,"last_updated":17,"update_note":9,"status":18,"stages":19,"call_frequency":9,"next_call_expected":9,"source_url":7,"created_at":20,"updated_at":21,"last_seen_at":21,"eligible_countries":22,"description":24,"seo_summary":25,"recurring_round":14,"canonical_id":4,"links":26},"research-council-of-norway-iics4all-multi-national-investigator-initiated-cli-2027-01","IICS4all: Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations","Research Council of Norway","https:\u002F\u002Fwww.forskningsradet.no\u002Fen\u002Fcall-for-proposals\u002FInternational-joint-calls\u002Fmulti-national-investigator-initiated-clinical-studies-cardiovascular-autoimmune-metabolic-non-communicable-respiratory-diseases-underrepresented-populations\u002F","€1.3M",null,1300000,"2027-01-14T00:00:00.000Z","Full proposal deadline 14 June 2027","3-6",false,"Required — transnational multi-national clinical study consortium","2026-11-08T00:00:00.000Z","2026-11-15T00:00:00.000Z","open","2-stage: pre-proposal (14 January 2027) → full proposal (14 June 2027)","2026-11-08T09:51:18.912Z","2026-11-15T10:20:09.057Z",[23],"NO","Joint announcement with Regional Health Authorities for transnational investigator-initiated clinical trials; supports pragmatic phase III randomised controlled multi-national clinical studies, including underrepresented populations.","{\"summary\":\"IICS4all, funded through the Research Council of Norway under the ERA4Health partnership, supports investigator-initiated phase III randomised controlled clinical studies in cardiovascular, autoimmune, metabolic and non-communicable respiratory diseases, including studies covering underrepresented populations. The Norwegian allocation is €1.3M, provided jointly with the Regional Health Authorities, and applies to multi-national consortia submitting pragmatic, interventional trial proposals. The call runs as a two-stage process, with a pre-proposal ahead of the full proposal submission.\",\"meta_description\":\"IICS4all funds multi-national phase III clinical trials in cardiovascular, autoimmune, metabolic and respiratory disease, Norwegian stream, from Research Council of Norway.\",\"who_should_apply\":[\"Investigators leading pragmatic phase III randomised controlled trials\",\"Researchers based at Norwegian institutions participating in a multi-national consortium\",\"Studies in cardiovascular, autoimmune, metabolic or non-communicable respiratory disease\",\"Projects designed to include underrepresented populations\",\"Clinical teams with trial-ready interventions at TRL 6-7\"],\"key_dates\":[\"Pre-proposal deadline 14 January 2027, full proposal deadline 14 June 2027\",\"Two-stage process: pre-proposal then full proposal\",\"Norwegian funding stream delivered jointly with the Regional Health Authorities\"],\"tips\":[\"Confirm the multi-national consortium structure required under ERA4Health before the pre-proposal stage, since this is a joint call across partner countries.\",\"Frame the study as pragmatic and phase III with clear interventional design, the call specifically excludes earlier-phase or purely observational work.\",\"Address the underrepresented populations scope explicitly in the proposal, as it is named as a distinct focus of the call.\"],\"faq\":[{\"q\":\"How much funding is available for IICS4all in Norway?\",\"a\":\"The Norwegian allocation is €1.3M, provided jointly by the Research Council of Norway and the Regional Health Authorities.\"},{\"q\":\"What is the deadline for IICS4all?\",\"a\":\"The pre-proposal deadline is 14 January 2027, followed by a full proposal deadline of 14 June 2027.\"},{\"q\":\"Is a consortium required for IICS4all?\",\"a\":\"Yes, a multi-national consortium is required as part of the ERA4Health partnership.\"},{\"q\":\"What diseases does IICS4all cover?\",\"a\":\"The call funds studies in cardiovascular, autoimmune, metabolic and non-communicable respiratory diseases, including those involving underrepresented populations.\"},{\"q\":\"What type of clinical studies does IICS4all fund?\",\"a\":\"It funds pragmatic, phase III, randomised controlled, multi-national interventional investigator-initiated clinical studies.\"}],\"tags\":[\"cardiovascular-disease\",\"autoimmune-disease\",\"metabolic-disease\",\"respiratory-disease\",\"clinical-trials\",\"era4health\",\"norway\",\"consortium-required\"]}",{"matchedProgram":9,"resourceSlug":9,"relatedGuides":27,"countryHubs":28,"domainHubs":29,"closingMonth":33,"hasRelated":14,"hasBrowseRelated":36},[],[],[30],{"slug":31,"name":32},"cardiovascular","Cardiovascular",{"slug":34,"label":35},"2027-01","January 2027",true,{"grants":38},[39,43,48,53,56],{"id":40,"name":41,"funder":42,"deadline":11,"budget":9},"european-commission-era4health-joint-transnational-call-iics4all-2027-01","ERA4Health Joint Transnational Call – IICS4all","European Commission",{"id":44,"name":45,"funder":46,"deadline":11,"budget":47},"hrb-era4health-iics4all-2027","ERA4Health IICS4all 2027","HRB","Up to €650,000 per grant (HRB contribution); up to €1,500,000 total HRB commitment to the call",{"id":49,"name":50,"funder":51,"deadline":52,"budget":9},"swedish-research-council-project-grant-for-international-collaboration-with-2027-01","Project grant for international collaboration within health research (ERA4HEALTH)","Swedish Research Council","2027-01-21T00:00:00.000Z",{"id":54,"name":55,"funder":42,"deadline":52,"budget":9},"regieorgaan-sia-transforming-health-and-care-systems-2027-01","Transforming Health and Care Systems",{"id":57,"name":58,"funder":6,"deadline":59,"budget":9},"research-council-of-norway-cell-and-gene-therapy-for-personalised-medicine-2027-01","Cell and Gene Therapy for Personalised Medicine","2027-01-20T00:00:00.000Z"]